Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
ELIXA also stands out from the other CVOT as it was the only trial enrolling patients with a recent acute coronary syndrome as opposed to CV events occurring 3 months before enrollment in all other trials
FDA in 2014 approved the higher dose version of this compound (known as Saxenda) for chronic weight-management treatment
We reviewed 100 research papers and summarised their aims, approaches, models, datasets, novelty, and limitations
We accounted for demographics, social vulnerability and rurality based on latest address, BMI category, diabetes, mental health diagnoses, and medications for opioid, alcohol, or nicotine use disorder
US$ 28.10
US$ 28.17
US$ 29.18
US$ 29.54
US$ 26.17
US$ 27.90
US$ 25.92
US$ 23.58
US$ 21.60
US$ 21.74
US$ 23.74
